Literature DB >> 19362996

Prevalence of HLA-B*5701 in HIV-infected patients in Spain (results of the EPI Study).

J Arrizabalaga1, F Rodriguez-Alcántara, J L Castañer, A Ocampo, D Podzamczer, F Pulido, M Riera, J Sanz, M Pascual-Bernaldez, R Dal-Re.   

Abstract

BACKGROUND: A hypersensitivity reaction (HSR) is associated with abacavir (ABC), a nucleoside reverse transcriptase inhibitor. Genetic association of ABC HSR with the presence of HLA-B*5701 has been demonstrated in PREDICT-1 study, showing a prevalence of 5.6% in HIV-infected population. However the prevalence of this allele in HIV-infected patients in Spain has not been established yet.
METHOD: This is a cross-sectional epidemiological study that included 1,198 patients in 74 centers that serve the HIV-infected population of Spain. HLA-B*5701 was checked both in the hospital lab and one central lab, showing an overall prevalence of this allele of 6%.
RESULTS: HLA-B*5701 was most prevalent in Caucasian population (6.5%). Concordance between the local and central lab was very high for positive and negative results (95.7% and 99.3%, respectively).
CONCLUSION: These aspects define this test as a useful tool for the management of HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362996     DOI: 10.1310/hct1001-048

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  4 in total

1.  The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.

Authors:  Mariola López; Alejandra Peris; Vincent Soriano; Sara Lozano; José Luis Vicario; Norma I Rallón; Clara Restrepo; José M Benito
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Frequency of HLA B*5701 allele carriers in abacavir treated-HIV infected patients and controls from northeastern Brazil.

Authors:  Sergio Crovella; Lara Biller; Sergio Santos; Ana Salustiano; Lucas Brandao; Rafael Guimaraes; Ludovica Segat; Jose Luiz de Lima Filho; Luiz Claudio Arraes
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  A Prospective Screening of HLA-B*57.01 Allelic Variant for Preventing the Hypersensivity Reaction to Abacavir: Experience from the Laboratory of Molecular Biology of the Infectious Diseases Division at the University Hospital of Salerno.

Authors:  C Senatore; B Charlier; A Truono; R Punzi; F D'Aniello; N Boffa; V Izzo; V Conti; G Russomanno; V Manzo; A Filippelli; M Mazzeo
Journal:  Transl Med UniSa       Date:  2014-12-19

4.  Prevalence of HLA-B*5701 and Its Relationship with Abacavir Hypersensitivity Reaction in Iranian HIV-Infected Patients.

Authors:  Shadi Baniasadi; Shokoufeh Baradaran Shokouhi; Payam Tabarsi; Maryam Alehashem; Hossein Khalili; Fanak Fahimi; Seyed Alireza Nadji
Journal:  Tanaffos       Date:  2016
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.